ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

October 25, 2013

In Brief: Walter To Retire, Search Starts For New DEA Deputy; Mary Fink Retires; NCCP Seeks Director

January 27, 1984

Imbruvica Improves PFS, OS In Phase III CLL Study

December 26, 2014

Cancer center investigators share Nobel Prizes in medicine, chemistry.

October 8, 2004

FDA Approves Lapatinib For Advanced Breast Cancer

March 30, 2007

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998